We have focused on developing tools across clinical scores, radiological methods and other omics to measure and predict disease progression trajectories and understanding and quantifying bowel damage in IBD. Ongoing interests include investigating radiomics in quantifying disease progression and novel PET tracers combined with MRI of the abdomen in differentiating inflammation from fibrosis.
- Prado E, Law CCY, Rowan C, Osman A, Gore E, Ballard DH, Ludwig DR, Tsai R, Gergely M, Geahchan A, Taouli B, Abboud G, Altinmakas E, Rajauria P, Colombel JF, Ungaro RC, Deepak P.Lemann Index for assessing bowel damage in Crohn’s disease: a real-world study. J Crohns Colitis. 2024 Jun 27:jjae102. PMID: 38935558
- Matt A, Li Y, Nix BD, Huang K, Jain U, Ma C, Zhou C, Deepak P. Sa1938 three-dimensional ex-vivo visualization of normal and inflamed small intestine and colonic tissue using optical coherence tomography. Gastroenterology. 2023 May 1;164(6):S-488.